Literature DB >> 31655905

Spectrophotometric and visual determination of zoledronic acid by using a bacterial cell-derived nanopaper doped with curcumin.

Shadab Faham1, Raouf Ghavami2, Hamed Golmohammadi3, Gholamreza Khayatian1.   

Abstract

A nanopaper-based analytical device (NAD) is described for a colorimetric metal-complexing indicator-displacement assay (M-IDA) for zoledronic acid (ZA). Bacterial cellulose nanopaper was doped with curcumin to obtain a chemosensor on which hydrophilic test zones were patterned via laser printing of hydrophobic walls. The color intensity of the test zones decreases in the presence of Fe(III) due to the formation of Fe(III)-curcumin complex. However, upon addition of ZA, Fe(III) ions preferably binds ZA. Subsequently, the color of the zone changes from light yellow to dark yellow. The changes in the absorption (measured at 427 nm) and of the color of the test stripe can be monitored visually, by using a digital camera, or by a spectrophotometer. Under optimal conditions, the analytical signals increase linearly in the 0.01-100 μM ZA concentration range, and the detection limits are 8.8 and 8.0 nM for smartphone and spectrophotometer-based methods, respectively. The method was employed to the determination of ZA in (spiked) urine, serum, saliva, and in pharmaceutical samples. Graphical abstract Schematic representation of a nanopaper-based analytical device based on curcumin-doped BC nanopaper (CDBC) integrated with smartphone for metal-complexing indicator-displacement assay of zoledronic acid (ZA). High affinity of ZA to Fe(III) on the NAD/CDBC leads to color change.

Entities:  

Keywords:  Cellulose nanopaper; Colorimetric; Curcumin; Zoledronic acid

Year:  2019        PMID: 31655905     DOI: 10.1007/s00604-019-3815-9

Source DB:  PubMed          Journal:  Mikrochim Acta        ISSN: 0026-3672            Impact factor:   5.833


  21 in total

1.  A validated stability indicating ion-pair RP-LC method for zoledronic acid.

Authors:  B Mallikarjuna Rao; M K Srinivasu; Ch Prathima Rani; S Siva kumar; P Rajender Kumar; K B Chandrasekhar; M Veerender
Journal:  J Pharm Biomed Anal       Date:  2005-09-15       Impact factor: 3.935

2.  Simple analysis of four bisphosphonates simultaneously by reverse phase liquid chromatography using n-amylamine as volatile ion-pairing agent.

Authors:  Zan Xie; Ye Jiang; Di-Qun Zhang
Journal:  J Chromatogr A       Date:  2006-02-03       Impact factor: 4.759

3.  Lab-on-nanopaper: An optical sensing bioplatform based on curcumin embedded in bacterial nanocellulose as an albumin assay kit.

Authors:  Tina Naghdi; Hamed Golmohammadi; Maryam Vosough; Mojgan Atashi; Iman Saeedi; Mohammad Taghi Maghsoudi
Journal:  Anal Chim Acta       Date:  2019-04-20       Impact factor: 6.558

4.  Development and validation of a highly sensitive RIA for zoledronic acid, a new potent heterocyclic bisphosphonate, in human serum, plasma and urine.

Authors:  Francois Legay; Sonia Gauron; Fabienne Deckert; Ghislaine Gosset; Ulrike Pfaar; Christina Ravera; Hansjörg Wiegand; Horst Schran
Journal:  J Pharm Biomed Anal       Date:  2002-11-07       Impact factor: 3.935

5.  Clinical outcome and prognostic factors in hepatocellular carcinoma patients with bone metastases medicated with zoledronic acid.

Authors:  Yohji Honda; Hiroshi Aikata; Fumi Honda; Norihito Nakano; Yuki Nakamura; Masahiro Hatooka; Kei Morio; Tomoki Kobayashi; Takayuki Fukuhara; Yuko Nagaoki; Tomokazu Kawaoka; Akira Hiramatsu; Michio Imamura; Yoshiiku Kawakami; Kazuaki Chayama
Journal:  Hepatol Res       Date:  2016-12-08       Impact factor: 4.288

6.  Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.

Authors:  Andrew L Himelstein; Jared C Foster; James L Khatcheressian; John D Roberts; Drew K Seisler; Paul J Novotny; Rui Qin; Ronald S Go; Stephen S Grubbs; Tracey O'Connor; Mario R Velasco; Douglas Weckstein; Ann O'Mara; Charles L Loprinzi; Charles L Shapiro
Journal:  JAMA       Date:  2017-01-03       Impact factor: 56.272

7.  Determination of Zoledronic Acid and Its Related Substances by High Performance Liquid Chromatography with Evaporative Light Scattering Detection.

Authors:  Rifat Emre Burmaoglu; Serap Saglik Aslan
Journal:  J Chromatogr Sci       Date:  2019-01-01       Impact factor: 1.618

Review 8.  The Essential Medicinal Chemistry of Curcumin.

Authors:  Kathryn M Nelson; Jayme L Dahlin; Jonathan Bisson; James Graham; Guido F Pauli; Michael A Walters
Journal:  J Med Chem       Date:  2017-01-11       Impact factor: 7.446

9.  Reactive oxygen species are required for zoledronic acid-induced apoptosis in osteoclast precursors and mature osteoclast-like cells.

Authors:  Ta-Wei Tai; Ching-Yu Chen; Fong-Chin Su; Yuan-Kun Tu; Tsung-Ting Tsai; Chiou-Feng Lin; I-Ming Jou
Journal:  Sci Rep       Date:  2017-03-10       Impact factor: 4.379

10.  Long-term safety of monthly zoledronic acid therapy beyond 1 year in patients with advanced cancer involving bone (LoTESS): A multicentre prospective phase 4 study.

Authors:  A A Khalafallah; M Slancar; W Cosolo; E Abdi; B Chern; R J Woodfield; M C Copeman
Journal:  Eur J Cancer Care (Engl)       Date:  2017-01-30       Impact factor: 2.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.